glucose oxidase
Biologicalexperimental
The glucose oxidase enzyme also known as notatin is an oxidoreductase that catalyses the oxidation of glucose to hydrogen peroxide and D-glucono-δ-lactone. This enzyme is produced by certain species of fungi and insects and displays antibacterial activity when oxygen and glucose are present. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2012 (NCT01883427)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Hydroxyacid oxidase 1Supplementation
HAO1 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGlucose oxidase ↗
- ChEMBLCHEMBL2108700 ↗
Also known as
- component of e-101
- glucose oxidase
- glucose oxidase
- glucose oxidase
- glucose oxidase
- go
- go
- go; component of e-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01883440 | Phase 2 | Jan 1, 2013 | Umea University, Umeå University |
| NCT01883427 | Phase 2 | Oct 1, 2012 | Norrbottens Landsting, Umea University, Umeå University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Umea University | Academic/Hospital | 2 | 0 | 1 | 2012 |
| Umeå University | Academic/Hospital | 2 | 2 | 1 | 2012 |
| Norrbottens Landsting | Government | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1